About Topotarget Topotarget (NASDAQ OMX: TOPO) is a Scandinavian based international biotech company headquartered in Denmark, dedicated to improve cancer therapies. In collaboration with Spectrum Pharmaceuticals, Inc. Topotarget currently focuses on the development in pivotal studies of its lead drug candidate, belinostat, which has demonstrated a clear anti neoplastic effect in both hematological malignancies and solid tumors. Belinostat can be used in combination with full doses of chemotherapy, and is currently in a pivotal trial within peripheral T-cell lymphoma (PTCL) and phase 2 in Cancer of Unknown Primary (CUP). Topotarget’s key cancer drug targets are HDAC, NAD+, mTOR, Fas ligand and topoisomerase II. Totect
View Top Employees from TopoTarget A/SWebsite | http://www.topotarget.com |
Employees | 21 (11 on RocketReach) |
Founded | 2000 |
Industry | Biotechnology, Drug Discovery, Science and Engineering, Pharmaceuticals, Pharmaceutical, Health Care |
Looking for a particular TopoTarget A/S employee's phone or email?
11 people are employed at TopoTarget A/S.